U.S. flag

An official website of the United States government

NM_001035.3(RYR2):c.13957G>T (p.Val4653Phe) AND Catecholaminergic polymorphic ventricular tachycardia 1

Germline classification:
Pathogenic/Likely pathogenic (3 submissions)
Last evaluated:
Nov 10, 2014
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000013827.31

Allele description [Variation Report for NM_001035.3(RYR2):c.13957G>T (p.Val4653Phe)]

NM_001035.3(RYR2):c.13957G>T (p.Val4653Phe)

Gene:
RYR2:ryanodine receptor 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1q43
Genomic location:
Preferred name:
NM_001035.3(RYR2):c.13957G>T (p.Val4653Phe)
HGVS:
  • NC_000001.11:g.237798037G>T
  • NG_008799.3:g.760854G>T
  • NM_001035.3:c.13957G>TMANE SELECT
  • NP_001026.2:p.Val4653Phe
  • LRG_402t1:c.13957G>T
  • LRG_402:g.760854G>T
  • LRG_402p1:p.Val4653Phe
  • NC_000001.10:g.237961337G>T
  • NG_008799.2:g.760636G>T
  • NM_001035.2:c.13957G>T
  • Q92736:p.Val4653Phe
Protein change:
V4653F; VAL4653PHE
Links:
UniProtKB: Q92736#VAR_011403; OMIM: 180902.0008; dbSNP: rs121918604
NCBI 1000 Genomes Browser:
rs121918604
Molecular consequence:
  • NM_001035.3:c.13957G>T - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Name:
Catecholaminergic polymorphic ventricular tachycardia 1
Synonyms:
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; Stress-induced polymorphic ventricular tachycardia; VENTRICULAR TACHYCARDIA, STRESS-INDUCED POLYMORPHIC 1
Identifiers:
MONDO: MONDO:0011484; MedGen: C1631597; Orphanet: 3286; OMIM: 604772

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000034074OMIM
no assertion criteria provided
Pathogenic
(Jun 29, 2004)
germlineliterature only

PubMed (2)
[See all records that cite these PMIDs]

SCV000057858GeneReviews
no classification provided
not providedunknownliterature only

PubMed (2)
[See all records that cite these PMIDs]

SCV000207212Blueprint Genetics
no assertion criteria provided
Likely pathogenic
(Nov 10, 2014)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedunknownnot providednot providednot providednot providednot providednot providedliterature only
not providedgermlineyes1not providednot providednot providednot providedclinical testing

Citations

PubMed

Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis.

Priori SG, Chen SR.

Circ Res. 2011 Apr 1;108(7):871-83. doi: 10.1161/CIRCRESAHA.110.226845. Review.

PubMed [citation]
PMID:
21454795
PMCID:
PMC3085083

Catecholaminergic Polymorphic Ventricular Tachycardia.

Napolitano C, Mazzanti A, Bloise R, Priori SG.

2004 Oct 14 [updated 2022 Jun 23]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2024.

PubMed [citation]
PMID:
20301466
See all PubMed Citations (4)

Details of each submission

From OMIM, SCV000034074.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (2)

Description

Laitinen et al. (2001) reported a val4653-to-phe (V4653F) mutation in the RYR2 gene in a large Finnish family with a history of stress-induced ventricular tachycardia (CPVT1; 604772) and sudden unexplained death. This mutation was located in the carboxy-terminal part of the cardiac ryanodine receptor, which contains several membrane-spanning domains.

Lehnart et al. (2004) simulated the effects of exercise on mutant RYR2 channels using PKA phosphorylation. The V4653F mutant exhibited decreased binding of calstabin-2, a subunit that stabilizes the closed state of the channel. After PKA phosphorylation, the mutant showed a significant gain-of-function defect consistent with leaky Ca(2+)-release channels and a significant rightward shift in the half-maximal inhibitory magnesium concentration. Treatment with an experimental drug enhanced the binding of calstabin-2 to RYR2 and normalized channel function.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From GeneReviews, SCV000057858.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownnot providednot providednot providedAssert pathogenicitynot providednot providednot providednot provided

From Blueprint Genetics, SCV000207212.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

Last Updated: Apr 6, 2024